Consensus on clinical application of immunoglobulin G4.
10.3760/cma.j.cn112138-20230929-00172
- Collective Name:National Clinical Research Center for Dermatologic and Immunologic Diseases (Peking Union Medical College Hospital) Experimental Diagnosis Research Committee;Rheumatology and Immunology Physicians Committee of Chinese Medical Doctor Association, Autoantibodies Detection Committee;Chinese Rheumatism Data Center
- Publication Type:Journal Article
- MeSH:
Humans;
China;
Consensus;
Immunoglobulin G/blood*
- From:
Chinese Journal of Internal Medicine
2024;63(1):35-40
- CountryChina
- Language:Chinese
-
Abstract:
IgG4 is a subclass of IgG. Elevated serum IgG4 levels are an important serological feature of IgG4 related diseases and serve as a serological marker for assessing disease activity and severity. The harmonization of IgG4 detection is crucial for its clinical application. National Clinical Research Center for Dermatologic and Immunologic Diseases (Peking Union Medical College Hospital), Experimental Diagnosis Research Committee, Rheumatology and Immunology Physicians Committee of Chinese Medical Doctor Association, Autoantibodies Detection Committee, and Chinese Rheumatism Data Center have organized clinical and laboratory experts to draft this consensus, aiming to standardize IgG4 detection and provide guideline for clinician and laboratory experts to appropriate utility and interpret IgG4 results in China.
